A Study of SH009 Injection in Patients With Advanced Solid Tumors.

NCT07390838 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Cancer (Locally Advanced or Metastatic)
Lung Cancer (NSCLC)
Head and Neck Cancer Squamous Cell Carcinoma
Breast Cancer (Locally Advanced or Metastatic)
Esophageal Cancer
Gastric Cancer (GC)
Solid Tumor Malignancies

Interventions

DRUG: SH009

Sponsor

Nanjing Sanhome Pharmaceutical, Co., Ltd.